EDGAR Filing Documents for 0000318306-15-000028

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000318306-15-000028

Filing Date

2015-05-14

Accepted

2015-05-14 16:13:27

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	a10q-033115.htm	10-Q	381387
2	PRINCIPAL EXECUTIVE OFFICER CERTIFICATION	ex_31-1.htm	EX-31.1	20492
3	PRINCIPAL FINANCIAL OFFICER CERTIFICATION	ex_31-2.htm	EX-31.2	20914
4	PRINCIPAL EXECUTIVE OFFICER CERTIFICATION	ex_32-1.htm	EX-32.1	5532
5	PRINCIPAL FINANCIAL OFFICER CERTIFICATION	ex_32-2.htm	EX-32.2	5384
	Complete submission text file	0000318306-15-000028.txt		1920570

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE REPORT	accp-20150331.xml	EX-101.INS	163943
7	XBRL TAXONOMY SCHEMA	accp-20150331.xsd	EX-101.SCH	13351
8	XBRL CALCULATION LINKBASE	accp-20150331_cal.xml	EX-101.CAL	34968
9	XBRL DEFINITION LINKBASE	accp-20150331_def.xml	EX-101.DEF	43034
10	XBRL LABEL LINKBASE	accp-20150331_lab.xml	EX-101.LAB	209205
11	XBRL PRESENTATION LINKBASE	accp-20150331_pre.xml	EX-101.PRE	120050

Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207

Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100

PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)